AIM ImmunoTech Inc. Share Price
AMEX: AIM | Micro CapAIM ImmunoTech Inc. Stock Performance
Open $0.26 | Prev. Close $0.28 | Circuit Range N/A |
Day Range $0.26 - $0.29 | Year Range $0.22 - $2.91 | Volume 8,528 |
Average Traded $0.28 |
AIM ImmunoTech Inc. Share Price Today
As of 9 August 2026, AIM ImmunoTech Inc.'s share price is $0.27. The stock opened at $0.26, compared to its previous close of $0.28. During today's trading session, AIM ImmunoTech Inc.'s share price traded between $0.26 and $0.29, with an average price of $0.28. Over the past 52 weeks, the stock has recorded a high of $2.91 and a low of $0.22. In terms of performance, AIM ImmunoTech Inc.'s share price has declined by 69.59% over the last six months and is down 89.07% on a year-on-year basis.
AIM ImmunoTech Inc. Share Price Chart
AIM ImmunoTech Inc. Stock Fundamentals & Key Indicators
Market Cap $444957.81 | PE Ratio (TTM) -0.03 | Dividend Yield N/A |
EPS (TTM) $-8.62 | Revenue (TTM) $88000.00 | Return On Equity (TTM) 142.68% |
Profit Margin -15861.36% | Debt to Equity -0.64 | Quarterly Earnings Growth YoY 11.24% |
AIM ImmunoTech Inc. Quarterly Profit & Loss
All figures in USD
AIM ImmunoTech Inc. Annual Profit & Loss
All figures in USD
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida.
AIM ImmunoTech Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $0.26 | $0.28 | +10.12% |
Jul 2026 | $0.28 | $0.26 | -7.55% |
Jun 2026 | $0.56 | $0.28 | -32.52% |
May 2026 | $0.53 | $0.41 | -21.22% |
Apr 2026 | $0.60 | $0.52 | -6.10% |
Mar 2026 | $0.93 | $0.56 | -38.38% |
Feb 2026 | $1.11 | $0.90 | -24.67% |
Jan 2026 | $1.20 | $1.20 | +8.11% |
Dec 2025 | $1.59 | $1.11 | -26.73% |
Nov 2025 | $2.02 | $1.51 | -28.20% |
Oct 2025 | $2.70 | $2.11 | -20.38% |
Sep 2025 | $2.46 | $2.65 | +5.37% |
AIM Share Price FAQs
What is AIM ImmunoTech Inc. share price today?
What is the 52 week high and 52 week low of AIM ImmunoTech Inc. stock?
What is AIM's market capitalisation today?
What is AIM's net income for the last quarter?
What is the 5 year returns of AIM?
What is the high & low stock price of AIM today?
Can I buy AIM shares in India?